Role of different bombesin receptor subtypes mediating contractile activity in cat upper gastrointestinal tract.
Mammalian bombesin-like peptides, gastrin-releasing peptide (GRP) and neuromedin B (NMB) are known to increase the motility of different segments in the gut. The present study was carried out to identify the bombesin receptor subtypes mediating the contractions induced by exogenous bombesin-like peptides in muscle strips isolated from cat esophagus, fundus, and duodenum. Both GRP-10 and NMB evoked concentration-dependent contractions in circular strips of esophagus and fundus and in longitudinal strips of the duodenum. These contractions were tetrodotoxin- and atropine-resistant. The potency of NMB in esophageal strips was 33 times higher than that of GRP-10. The NMB-preferring receptor antagonists D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH2 (SSocta) and D-Nal-cyclo[Cys-Tyr-D-Trp-Orn-Val-Cys]-Nal-NH2 (BIM-23127) shifted the NMB and GRP concentration-response curves to the right, while the GRP-preferring receptor antagonist [D-Phe6]Bombesin(6-13)-methyl-ester (BME) did not affect the response to the peptides. Isolated muscle strips from the cat fundus and duodenum showed a higher sensitivity to GRP-10 than to NMB. In both segments, BME shifted the GRP-10 and NMB concentration-response curves to the right, while SSocta had no effect. The antagonism of BME was competitive on duodenal but not competitive on fundic muscle. We conclude that the direct myogenic action of GRP-10 and NMB in the esophagus is mediated mainly via NMB-preferring receptors, while GRP-preferring receptors are responsible for the contractile responses to bombesin-like peptides in feline fundus and duodenum. Our data suggest that the GRP receptor population located on fundic muscle might be nonhomogeneous.
Milusheva
E A
EA
Institute of Physiology, Bulg. Acad. Sci., Sofia, Bulgaria.
Kortezova
N I
NI
Mizhorkova
Z N
ZN
Papasova
M
M
Coy
D H
DH
Bálint
A
A
Vizi
E S
ES
Varga
G
G
D000818:Animals; D001839:Bombesin / Q000494:pharmacology; D002415:Cats; D004386:Duodenum / Q000502:physiology; D004947:Esophagus / Q000502:physiology; D005748:Gastric Fundus / Q000502:physiology; D005769:Gastrointestinal Motility; D066298:In Vitro Techniques; D009119:Muscle Contraction; D015287:Neurokinin B / Q000031:analogs & derivatives / Q000494:pharmacology; D010446:Peptide Fragments / Q000494:pharmacology; D010456:Peptides, Cyclic / Q000494:pharmacology; D018004:Receptors, Bombesin / Q000819:agonists / Q000145:classification / Q000502:physiology*
C092829:BIM 23127; D010446:Peptide Fragments; D010456:Peptides, Cyclic; D018004:Receptors, Bombesin; C040794:neuromedin C; D015287:Neurokinin B; C038393:neuromedin B; D001839:Bombesin